vTv Therapeutics (VTVT) Other Working Capital Changes (2017 - 2026)
vTv Therapeutics (VTVT) reported Other Working Capital Changes of -$17000.0 for Q1 2026, up 71.67% on a YoY basis from -$9902.9 in Q1 2025, and down 104.3% sequentially from $395000.0 in Q4 2025.
vTv Therapeutics (VTVT) Other Working Capital Changes (2017 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 13 years of Other Working Capital Changes data on file, last reported at -$17000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes changed N/A year-over-year to -$16.8 million; the trailing twelve-month figure through Mar 2026 stood at -$16.8 million (down 187000.0% YoY), and the FY2024 full-year result was -$17000.0, changed N/A from the prior year.
- Other Working Capital Changes slipped to -$16.8 million in Q1 2026, from -$9000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$9000.0 in Q4 2022 to a low of -$16.8 million in Q1 2026.
- A 5-year average of $23882.4 and a median of -$17000.0 in 2026 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 351.35% in 2024 and jumped 524.73% in 2025, its largest moves.
- Tracing VTVT's Other Working Capital Changes over 2 years: stood at -$9000.0 in 2022, then tumbled by 187000.0% to -$16.8 million in 2026.
- Business Quant data shows VTVT's Other Working Capital Changes at -$16.8 million in Q1 2026, -$9000.0 in Q4 2022, and -$9000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.84 Mn |
| Mar 31, 2026 | -16.84 Mn |
| Mar 31, 2026 | -16.84 Mn |
| Dec 31, 2022 | -9,000.00 |
| Dec 31, 2022 | -9,000.00 |
| Dec 31, 2022 | -9,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Mar 31, 2021 | -987,000.00 |
| Mar 31, 2021 | -987,000.00 |
| Mar 31, 2021 | -987,000.00 |
| Dec 31, 2020 | -8,000.00 |
| Dec 31, 2020 | -8,000.00 |
| Dec 31, 2020 | -8,000.00 |
| Sep 30, 2020 | -8,000.00 |
| Sep 30, 2020 | -8,000.00 |